Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study will be conducted to study the effect of virtual reality therapy on prostaglandin levels in adolescent females with primary dysmenorrhea.
Primary dysmenorrhea is thought to be caused by excessive levels of prostaglandins, which are hormones that stimulate the uterus to contract during menstruation and childbirth, Treatment must be tailored to individual patient symptoms. Pharmacologic management with non-steroidal anti-inflammatory medications and/or combined hormonal contraceptives is most common. Heat therapy, exercise, vitamins and dietary supplements have limited evidence and can be offered for patients seeking non-pharmacologic adjunctive or alternative options. Greater awareness for both health-care providers and patients allow for early intervention to reduce impact on quality of life and life course potential. The significance of this study to assess the effect of virtual reality therapy on primary dysmenorrhea.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Pharmacological treatment | Other | It will consist of 25 girls, who will receive pharmacological treatment in the form of ibuprofen 400 mg, three times per day, during the first 2 days of menstruation, for 3 menstrual cycles. |
|
| Virtual reality + Pharmacological treatment | Experimental | It will consist of 25 girls, who will receive the same pharmacological treatment in addition to virtual reality during the first 2 days of menstruation, for 3 menstrual cycles. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Pharmacological treatment | Drug | All participants in the two groups will receive pharmacological treatment in the form of ibuprofen 400 mg, three times per day, during the first 2 days of menstruation, for 3 menstrual cycles. |
| Measure | Description | Time Frame |
|---|---|---|
| Visual Analogue Scale (VAS) | Participants in both groups will complete the visual analogue scale (VAS) before the start of treatment and after 3 menstrual cycles of treatment. The VAS is a 10 cm horizontal line on which the participants' pain intensity is represented by a point between the extremes of "no pain at all "and "worst pain imaginable". Each girl will be asked to mark a point on the line between the extreme that was related to her pain intensity. Then, the distance will be measured each time from the left end of the line to the marked point to obtain the VAS score for pain intensity of dysmenorrhea. | 12 weeks |
| Assessment of Prostaglandin Levels | Blood samples will be collected from each girl in both groups to measure the levels of plasma PGF2α before the start of treatment and after 3 menstrual cycles of treatment. | 12 weeks |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Sally Mohamed Saeed, PhD | Contact | +20 100 466 9647 | sally_hashem@outlook.com |
| Name | Affiliation | Role |
|---|---|---|
| Sally Mohamed Saeed, PhD | Lecturer, Benha National University | Principal Investigator |
| Malak Adel El Mahdy, PhD | Lecturer, Al Hayah University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Misr University for Science and Technology | Giza | Egypt |
Not provided
| ID | Term |
|---|---|
| D004358 | Drug Therapy |
| D007052 | Ibuprofen |
| ID | Term |
|---|---|
| D013812 | Therapeutics |
| D010666 | Phenylpropionates |
| D000146 | Acids, Carbocyclic |
| D002264 | Carboxylic Acids |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Virtual reality | Other | The experimental group will receive virtual reality during the first 2 days of menstruation, for 3 menstrual cycles. |
|
| Sarah Abdullah Mohamed Elsamahy, PhD, PhD |
| Lecturer, Misr University for Science and Technology |
| Principal Investigator |
| Samah Mahmoud Ahmed sheha, PhD | Lecturer, Misr University for Science and Technology | Principal Investigator |
| Naglaa fathey moustafa, PhD | Lecturer, Al Hayah University | Principal Investigator |
| D009930 |
| Organic Chemicals |